Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (25)

Search Parameters:
Keywords = Miguel Piñero

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 640 KiB  
Article
Transforming Patient Experience: Real-World Impact of Mepolizumab on Symptom Burden in Chronic Rhinosinusitis with Nasal Polyps—A Multicenter Perspective
by Alfonso García-Piñero, Tomás Pérez-Carbonell, María-José Gómez-Gómez, Encarna Domenech-Campos, Fernando Martinez-Expósito, Noelia Muñoz-Fernández, Jordi Calvo-Gómez, Carmen García-Navalón, Lucas Fito-Martorell, Felip Ferrer-Baixauli, Ainhoa García-Lliberós, Nezly Mosquera-Lloreda, Chakib Taleb, Carlos Zac-Romero, Cecilia López-Valdivia, Juan Pardo-Albiach and Miguel Armengot-Carceller
J. Clin. Med. 2025, 14(15), 5248; https://doi.org/10.3390/jcm14155248 - 24 Jul 2025
Viewed by 407
Abstract
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic upper airway disease that may involve different inflammatory endotypes, although in Western populations it is most commonly associated with type 2 inflammation. CRSwNP has a significant impact on the patient’s quality of [...] Read more.
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic upper airway disease that may involve different inflammatory endotypes, although in Western populations it is most commonly associated with type 2 inflammation. CRSwNP has a significant impact on the patient’s quality of life. The recommended appropriate medical therapy is effective in controlling CRSwNP symptoms in many patients; however, a subset continues to exhibit persistent type 2 inflammation, evidenced by recurrent nasal polyps, elevated eosinophil counts, or the need for systemic corticosteroids or surgery. Monoclonal antibodies have recently become a novel and personalized treatment that can help refractory patients restore disease control. Objective: The present study aims to evaluate the effectiveness of mepolizumab in real-world settings in a diverse patient population, focusing on assessing the impact of this therapy on patient-reported outcomes after six months of treatment. Methods: This is a multicenter, observational study of CRSwNP patients treated with mepolizumab carried out in five hospitals located in Spain. Adult patients with a diagnosis of uncontrolled CRSwNP were included in the study. The change in the nasal polyp score (NPS) was the main clinical endpoint. Changes in the Sinonasal Outcome Test (SNOT-22), nasal congestion and smell impairment visual analogue scale scores, and blood and nasal polyp tissue eosinophil counts were among other endpoints included. Results: In total, 47 patients were included, and 91% were asthmatic. The nasal polyp score (0–8) was reduced significantly in the cohort (mean change: −2.56, p < 0.0001). The mean SNOT-22 score improved 25.29 points. Nasal congestion (−3.57, p < 0.0001) and smell impairment (−4.0, p < 0.0001) visual analog scale scores (0–10) showed a significant improvement. Blood and tissue eosinophil median counts showed significant reductions versus baseline of 86% and 26%, respectively. Among those patients with asthma, the asthma control test score achieved a median value of 24 points. Conclusions: This study provides real-world evidence supporting the effectiveness of mepolizumab in managing CRSwNP in patients with features suggestive of type 2 inflammation. The observed improvements in patient-reported outcomes, nasal polyp burden, and asthma control suggest that mepolizumab may be a valuable therapeutic option for this patient population. Full article
(This article belongs to the Section Otolaryngology)
Show Figures

Figure 1

11 pages, 1017 KiB  
Article
Emergence of Two Different Genotypes of Bagaza Virus (BAGV) Affecting Red-Legged Partridges in Spain, in 2019 and 2021
by Pilar Aguilera-Sepúlveda, Belén Gómez-Martín, Montserrat Agüero, Miguel Ángel Jiménez-Clavero and Jovita Fernández-Pinero
Pathogens 2024, 13(9), 724; https://doi.org/10.3390/pathogens13090724 - 27 Aug 2024
Cited by 3 | Viewed by 948
Abstract
Bagaza virus (BAGV) is a flavivirus that affects avian species. In Europe, it was detected for the first time in Spain in 2010, exhibiting high genetic relatedness to Israel turkey meningoencephalomyelitis virus (ITMV) isolates from Israel. After a period of epidemiological silence, BAGV [...] Read more.
Bagaza virus (BAGV) is a flavivirus that affects avian species. In Europe, it was detected for the first time in Spain in 2010, exhibiting high genetic relatedness to Israel turkey meningoencephalomyelitis virus (ITMV) isolates from Israel. After a period of epidemiological silence, BAGV re-emerged, causing important outbreaks in 2019 and 2021. This study aims to characterize the newly detected strains and to elucidate if these recent outbreaks were caused by single or different virus introductions into the country. Hence, Spanish BAGV isolates from 2019 (n = 3) and 2021 (n = 1) outbreaks, obtained from red-legged partridges in Cádiz, were sequenced and further characterized. The phylogenetic analyses showed that they belong to two different genotypes: BAGV-Genotypes 1 and 2. Isolates from 2019 belong to BAGV-Genotype 1, closely related to isolates from Senegal, where BAGV has been circulating for decades. In turn, the 2021 isolates belong to BAGV-Genotype 2, closely related to those detected in Spain in 2010. Additionally, the comparison of the viral polyproteins of several BAGV isolates from both genotypes supports and confirms the phylogenetic findings. To conclude, BAGV has been introduced into Spain on at least three independent occasions, with alternating genetic clades, thus confirming that BAGV is able to sporadically reach Southern Europe. Full article
Show Figures

Figure 1

32 pages, 8907 KiB  
Article
Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation
by Paula Cilleros-Holgado, David Gómez-Fernández, Rocío Piñero-Pérez, José Manuel Romero Domínguez, Marta Talaverón-Rey, Diana Reche-López, Juan Miguel Suárez-Rivero, Mónica Álvarez-Córdoba, Ana Romero-González, Alejandra López-Cabrera, Marta Castro De Oliveira, Andrés Rodríguez-Sacristan and José Antonio Sánchez-Alcázar
Biomolecules 2024, 14(5), 598; https://doi.org/10.3390/biom14050598 - 18 May 2024
Cited by 2 | Viewed by 2818
Abstract
Primary mitochondrial diseases result from mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) genes, encoding proteins crucial for mitochondrial structure or function. Given that few disease-specific therapies are available for mitochondrial diseases, novel treatments to reverse mitochondrial dysfunction are necessary. In this [...] Read more.
Primary mitochondrial diseases result from mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) genes, encoding proteins crucial for mitochondrial structure or function. Given that few disease-specific therapies are available for mitochondrial diseases, novel treatments to reverse mitochondrial dysfunction are necessary. In this work, we explored new therapeutic options in mitochondrial diseases using fibroblasts and induced neurons derived from patients with mutations in the GFM1 gene. This gene encodes the essential mitochondrial translation elongation factor G1 involved in mitochondrial protein synthesis. Due to the severe mitochondrial defect, mutant GFM1 fibroblasts cannot survive in galactose medium, making them an ideal screening model to test the effectiveness of pharmacological compounds. We found that the combination of polydatin and nicotinamide enabled the survival of mutant GFM1 fibroblasts in stress medium. We also demonstrated that polydatin and nicotinamide upregulated the mitochondrial Unfolded Protein Response (mtUPR), especially the SIRT3 pathway. Activation of mtUPR partially restored mitochondrial protein synthesis and expression, as well as improved cellular bioenergetics. Furthermore, we confirmed the positive effect of the treatment in GFM1 mutant induced neurons obtained by direct reprogramming from patient fibroblasts. Overall, we provide compelling evidence that mtUPR activation is a promising therapeutic strategy for GFM1 mutations. Full article
(This article belongs to the Special Issue Mitochondrial Quality Control in Aging and Neurodegeneration)
Show Figures

Figure 1

8 pages, 999 KiB  
Communication
Re-Emergence of a West Nile Virus (WNV) Variant in South Spain with Rapid Spread Capacity
by María José Ruiz-López, Pilar Aguilera-Sepúlveda, Sonia Cebrián-Camisón, Jordi Figuerola, Sergio Magallanes, Sarai Varona, Isabel Cuesta, Cristina Cano-Gómez, Patricia Sánchez-Mora, Juan Camacho, Carolina Sánchez-Peña, Francisco José Marchena, Ulises Ameyugo, Santiago Ruíz, María Paz Sánchez-Seco, Montserrat Agüero, Miguel Ángel Jiménez-Clavero, Jovita Fernández-Pinero and Ana Vázquez
Viruses 2023, 15(12), 2372; https://doi.org/10.3390/v15122372 - 1 Dec 2023
Cited by 6 | Viewed by 3047
Abstract
West Nile Virus (WNV) is a mosquito vector-borne zoonosis with an increasing incidence in Europe that has become a public health concern. In Spain, although local circulation has been known for decades, until 2020, when a large outbreak occurred, West Nile Virus cases [...] Read more.
West Nile Virus (WNV) is a mosquito vector-borne zoonosis with an increasing incidence in Europe that has become a public health concern. In Spain, although local circulation has been known for decades, until 2020, when a large outbreak occurred, West Nile Virus cases were scarce and mostly occurred in southern Spain. Since then, there have been new cases every year and the pathogen has spread to new regions. Thus, monitoring of circulating variants and lineages plays a fundamental role in understanding WNV evolution, spread and dynamics. In this study, we sequenced WNV consensus genomes from mosquito pools captured in 2022 as part of a newly implemented surveillance program in southern Spain and compared it to other European, African and Spanish sequences. Characterization of WNV genomes in mosquitoes captured in 2022 reveals the co-circulation of two WNV lineage 1 variants, the one that caused the outbreak in 2020 and another variant that is closely related to variants reported in Spain in 2012, France in 2015, Italy in 2021–2022 and Senegal in 2012–2018. The geographic distribution of these variants indicates that WNV L1 dynamics in southern Europe include an alternating dominance of variants in some territories. Full article
(This article belongs to the Special Issue Usutu Virus, West Nile Virus and Neglected Flaviviruses)
Show Figures

Figure 1

12 pages, 275 KiB  
Article
The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance
by Francisco Llorente, Elisa Pérez-Ramírez, Mayte Pérez-Olmeda, Desirée Dafouz-Bustos, Jovita Fernández-Pinero, Mercedes Martínez-Cortés and Miguel Ángel Jiménez-Clavero
Pathogens 2023, 12(11), 1360; https://doi.org/10.3390/pathogens12111360 - 16 Nov 2023
Viewed by 1484
Abstract
The presence of SARS-CoV-2 antibodies was examined over 7 months in a population of essential service workers exposed during the first epidemic wave in Madrid (Spain). Results obtained with different serological assays were compared. Firstly, serum samples obtained in April 2020 were analyzed [...] Read more.
The presence of SARS-CoV-2 antibodies was examined over 7 months in a population of essential service workers exposed during the first epidemic wave in Madrid (Spain). Results obtained with different serological assays were compared. Firstly, serum samples obtained in April 2020 were analyzed using eleven SARS-CoV-2 antibody detection methods, including seven ELISAs, two CLIAs and two LFAs. While all of the ELISA tests and the Roche eCLIA method showed good performance, it was poorer for the Abbott CLIA and LFA tests. Sera from 115 workers with serologically positive results in April were collected 2 and 7 months after the first sampling and were analyzed using five of the tests previously assessed. The results showed that while some ELISA tests consistently detected the presence of anti-SARS-CoV-2 antibodies even 7 months after first detection, other methods, such as the Abbott CLIA test, showed an important reduction in sensitivity for these mature antibodies. The sensitivity increased after establishing new cut-off values, calculated taking into account both recent and old infections, suggesting that an adjustment of assay parameters may improve the detection of individuals exposed to the infection. Full article
(This article belongs to the Collection SARS-CoV Infections)
14 pages, 2586 KiB  
Article
New Platinum Complexes from Salen- and Hydroxy-Substituted Salpn-Naphthalene Ligands with CO2 Reduction Activity
by Javier O. Rivera-Reyes, Joesene Soto-Pérez, Miguel Sepulveda-Pagán, Linguo Lu, Justin Borrero-Negrón, Alanys V. Luna-Ramírez, Pedro Trinidad-Pérez, Yomaira Pagán-Torres, Zhongfang Chen, Carlos R. Cabrera, William C. West, John-Paul Jones and Dalice M. Piñero Cruz
Catalysts 2023, 13(5), 911; https://doi.org/10.3390/catal13050911 - 22 May 2023
Cited by 3 | Viewed by 3308
Abstract
The electrocatalytic reduction of carbon dioxide (CO2) into added-value products is a promising alternative to completing the cycle of atmospheric CO2. We report two new platinum complexes—a salen-like naphthalene (PtL1) and a hydroxy-substituted salpn naphthalene (PtL2 [...] Read more.
The electrocatalytic reduction of carbon dioxide (CO2) into added-value products is a promising alternative to completing the cycle of atmospheric CO2. We report two new platinum complexes—a salen-like naphthalene (PtL1) and a hydroxy-substituted salpn naphthalene (PtL2)—that are capable of activating CO2 to produce carbon monoxide (CO). The predominant keto tautomer of the non-innocent ligands was determined using DFT calculations and UV-Vis spectroscopy. The PtL2 complex has a CO Faradaic efficiency >40% in the presence of water as a sacrificial proton source at −2.5 V vs. Fc/Fc+. The addition of the hydroxy group in combination with water as a proton source decreased the reduction potential and increased the CO formation tenfold when compared to PtL1. Full article
(This article belongs to the Section Electrocatalysis)
Show Figures

Graphical abstract

12 pages, 928 KiB  
Article
Relative Individual Sprint in Most Demanding Passages of Play in Spanish Professional Soccer Matches
by Juan Ángel Piñero, Marcos Chena, Juan Carlos Zapardiel, Alberto Roso-Moliner, Elena Mainer-Pardos, Miguel Lampre and Demetrio Lozano
Sports 2023, 11(4), 72; https://doi.org/10.3390/sports11040072 - 23 Mar 2023
Cited by 3 | Viewed by 3859
Abstract
(1) Background: The objective of this research was to analyse the most demanding passages (MDP) considering the sprint variable relative to the maximum level of sprint ability of each player as a function of player position, final outcome and part of the match [...] Read more.
(1) Background: The objective of this research was to analyse the most demanding passages (MDP) considering the sprint variable relative to the maximum level of sprint ability of each player as a function of player position, final outcome and part of the match during the competitive phase of a professional soccer season. (2) Methods: Global positioning system (GPS) data were collected from 22 players according to their playing position in the last 19 match days of the Spanish La Liga professional soccer in the 2020/2021 season. MDP were calculated from 80% of the maximum sprint speed of each player. (3) Results: Wide midfielders covered the greatest distance at >80% of the maximum speed (2.4 ± 1.63 seg) and the longest duration (21.91 ± 13.35 m) in their MDP. When the whole team was losing, it demonstrated greater distances (20.23 ± 13.04 m) and longer durations (2.24 ± 1.58 seg) compared to games in which it was winning. When the team ended up drawing, the relative sprint distance covered in the second half was significantly greater than in the first (16.12 ± 21.02; SD = 0.26 ± 0.28 (−0.03/−0.54). (4) Conclusions: Different demands of MDP, according to the sprint variable relative to the maximum individual capacity in competition, are required when contextual game factors are considered. Full article
(This article belongs to the Special Issue Advances in Physical Fitness Profile in Soccer Players)
Show Figures

Figure 1

14 pages, 272 KiB  
Article
“What to Do with the Dangerous Few?”: Abolition-Feminism, Monstrosity and the Reimagination of Sexual Harm in Miguel Piñero’s “Short Eyes”
by Laura E. Ciolkowski
Humanities 2023, 12(2), 25; https://doi.org/10.3390/h12020025 - 9 Mar 2023
Viewed by 3201
Abstract
The problem of child sexual abuse (CSA) is a crucial point of entry into abolition-feminist conversations about justice and punishment, healing and repair. The popular belief that the “child sex offender” is uniquely irredeemable, eternally depraved and dangerous can trouble abolition-feminist efforts to [...] Read more.
The problem of child sexual abuse (CSA) is a crucial point of entry into abolition-feminist conversations about justice and punishment, healing and repair. The popular belief that the “child sex offender” is uniquely irredeemable, eternally depraved and dangerous can trouble abolition-feminist efforts to address the devastating harm of CSA without reproducing the violence of prison and punishment. It also forces us to return to the question of “what to do with the dangerous few?” A familiar “tough on crime” refrain, this question mystifies the social, economic, and political conditions that nurture interpersonal violence. It also illustrates how centering our attention on “the monster in our midst” feeds an attachment to the mistaken belief that sexual harm is locatable in individual, bad people; that it is fixable by criminal law, and, in short, that justice and repair can be measured by the number of years one is sentenced to live behind bars. Miguel Piñero’s 1972 play “Short Eyes” exposes the failure of our attempts to incarcerate our way out of child sexual abuse and opens a literary-artistic space in which to explore the roots of violence and the abuse of power. The play dramatizes the particular ways in which the incarceration of those deemed the worst of the worst does not alleviate suffering or promote safety; rather, it prevents us from getting to the root of even the most horrific forms of abuse and from fully engaging, confronting and, finally, interrupting the daily, quotidian acts of sexual violence that are hiding in plain sight. Full article
(This article belongs to the Special Issue Twentieth-Century American Literature)
25 pages, 1461 KiB  
Review
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
by Paula Cilleros-Holgado, David Gómez-Fernández, Rocío Piñero-Pérez, Diana Reche-López, Mónica Álvarez-Córdoba, Manuel Munuera-Cabeza, Marta Talaverón-Rey, Suleva Povea-Cabello, Alejandra Suárez-Carrillo, Ana Romero-González, Juan Miguel Suárez-Rivero, Jose Manuel Romero-Domínguez and Jose Antonio Sánchez-Alcázar
Int. J. Mol. Sci. 2023, 24(2), 1482; https://doi.org/10.3390/ijms24021482 - 12 Jan 2023
Cited by 22 | Viewed by 6583
Abstract
Mitochondrial dysfunction is a key pathological event in many diseases. Its role in energy production, calcium homeostasis, apoptosis regulation, and reactive oxygen species (ROS) balance render mitochondria essential for cell survival and fitness. However, there are no effective treatments for most primary and [...] Read more.
Mitochondrial dysfunction is a key pathological event in many diseases. Its role in energy production, calcium homeostasis, apoptosis regulation, and reactive oxygen species (ROS) balance render mitochondria essential for cell survival and fitness. However, there are no effective treatments for most primary and secondary mitochondrial diseases to this day. Therefore, new therapeutic approaches, such as the modulation of the mitochondrial unfolded protein response (mtUPR), are being explored. mtUPRs englobe several compensatory processes related to proteostasis and antioxidant system mechanisms. mtUPR activation, through an overcompensation for mild intracellular stress, promotes cell homeostasis and improves lifespan and disease alterations in biological models of mitochondrial dysfunction in age-related diseases, cardiopathies, metabolic disorders, and primary mitochondrial diseases. Although mtUPR activation is a promising therapeutic option for many pathological conditions, its activation could promote tumor progression in cancer patients, and its overactivation could lead to non-desired side effects, such as the increased heteroplasmy of mitochondrial DNA mutations. In this review, we present the most recent data about mtUPR modulation as a therapeutic approach, its role in diseases, and its potential negative consequences in specific pathological situations. Full article
Show Figures

Figure 1

10 pages, 262 KiB  
Article
Validation of Childhood Rare Epilepsy Social Impact Assessment (CRESIA) to Measure the Social and Family Impact of Rare Childhood Diseases with Epilepsy
by Rafael Salom, Luis Miguel Aras, Jessica Piñero and Jon Andoni Duñabeitia
J. Clin. Med. 2022, 11(22), 6720; https://doi.org/10.3390/jcm11226720 - 13 Nov 2022
Cited by 4 | Viewed by 2460
Abstract
This study addresses the social relevance of low-prevalence childhood diseases and reports the process of generation and validation of a tool to assess the social impact on the direct family environment and the social context of reference. The aim of the process of [...] Read more.
This study addresses the social relevance of low-prevalence childhood diseases and reports the process of generation and validation of a tool to assess the social impact on the direct family environment and the social context of reference. The aim of the process of construction and validation of this instrument is to provide the field with a tool with the capacity to shed light on the social consequences of suffering from a low-prevalence disease, specifically those comorbid with treatment-resistant epileptic seizures of childhood origin. The instrument here presented and called CRESIA (acronym derived from Childhood Rare Epilepsy Social Impact Assessment) provides valuable information on six specific areas framing health, economic, psychological, social, and child-related stressors, as well as family. CRESIA represents a valid and reliable instrument for family members or primary caregivers of children and adolescents with childhood rare epilepsy. Full article
(This article belongs to the Section Clinical Neurology)
23 pages, 5192 KiB  
Article
Robocasting and Laser Micromachining of Sol-Gel Derived 3D Silica/Gelatin/β-TCP Scaffolds for Bone Tissue Regeneration
by María V. Reyes-Peces, Eduardo Félix, Francisco J. Martínez-Vázquez, Rafael Fernández-Montesinos, Óscar Bomati-Miguel, María del Mar Mesa-Díaz, Rodrigo Alcántara, José Ignacio Vilches-Pérez, Mercedes Salido, Nicolás De la Rosa-Fox and Manuel Piñero
Gels 2022, 8(10), 634; https://doi.org/10.3390/gels8100634 - 7 Oct 2022
Cited by 4 | Viewed by 2866
Abstract
The design and synthesis of sol-gel silica-based hybrid materials and composites offer significant benefits to obtain innovative biomaterials with controlled porosity at the nanostructure level for applications in bone tissue engineering. In this work, the combination of robocasting with sol-gel ink of suitable [...] Read more.
The design and synthesis of sol-gel silica-based hybrid materials and composites offer significant benefits to obtain innovative biomaterials with controlled porosity at the nanostructure level for applications in bone tissue engineering. In this work, the combination of robocasting with sol-gel ink of suitable viscosity prepared by mixing tetraethoxysilane (TEOS), gelatin and β-tricalcium phosphate (β-TCP) allowed for the manufacture of 3D scaffolds consisting of a 3D square mesh of interpenetrating rods, with macropore size of 354.0 ± 17.0 μm, without the use of chemical additives at room temperature. The silica/gelatin/β-TCP system underwent irreversible gelation, and the resulting gels were also used to fabricate different 3D structures by means of an alternative scaffolding method, involving high-resolution laser micromachining by laser ablation. By this way, 3D scaffolds made of 2 mm thick rectangular prisms presenting a parallel macropore system drilled through the whole thickness and consisting of laser micromachined holes of 350.8 ± 16.6-micrometer diameter, whose centers were spaced 1312.0 ± 23.0 μm, were created. Both sol-gel based 3D scaffold configurations combined compressive strength in the range of 2–3 MPa and the biocompatibility of the hybrid material. In addition, the observed Si, Ca and P biodegradation provided a suitable microenvironment with significant focal adhesion development, maturation and also enhanced in vitro cell growth. In conclusion, this work successfully confirmed the feasibility of both strategies for the fabrication of new sol-gel-based hybrid scaffolds with osteoconductive properties. Full article
(This article belongs to the Special Issue Bioceramics, Bioglasses and Gels for Tissue Engineering)
Show Figures

Figure 1

5 pages, 226 KiB  
Correction
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
by María Chaparro, Ana Garre, Andrea Núñez Ortiz, María Teresa Diz-Lois Palomares, Cristina Rodríguez, Sabino Riestra, Milagros Vela, José Manuel Benítez, Estela Fernández Salgado, Eugenia Sánchez Rodríguez, Vicent Hernández, Rocío Ferreiro-Iglesias, Ángel Ponferrada Díaz, Jesús Barrio, José María Huguet, Beatriz Sicilia, María Dolores Martín-Arranz, Xavier Calvet, Daniel Ginard, Inmaculada Alonso-Abreu, Luis Fernández-Salazar, Pilar Varela Trastoy, Montserrat Rivero, Isabel Vera-Mendoza, Pablo Vega, Pablo Navarro, Mónica Sierra, José Luis Cabriada, Mariam Aguas, Raquel Vicente, Mercè Navarro-Llavat, Ana Echarri, Fernando Gomollón, Elena Guerra del Río, Concepción Piñero, María José Casanova, Katerina Spicakova, Jone Ortiz de Zarate, Emilio Torrella Cortés, Ana Gutiérrez, Horacio Alonso-Galán, Álvaro Hernández-Martínez, José Miguel Marrero, Rufo Lorente Poyatos, Margalida Calafat, Lidia Martí Romero, Pilar Robledo, Orencio Bosch, Nuria Jiménez, María Esteve Comas, José María Duque, Ana María Fuentes Coronel, Manuela Josefa Sampedro, Eva Sesé Abizanda, Belén Herreros Martínez, Liliana Pozzati, Hipólito Fernández Rosáenz, Belén Crespo Suarez, Pilar López Serrano, Alfredo J. Lucendo, Margarita Muñoz Vicente, Fernando Bermejo, José Joaquín Ramírez Palanca, Margarita Menacho, Amalia Carmona, Raquel Camargo, Sandra Torra Alsina, Nuria Maroto, Juan Nerín de la Puerta, Elena Castro, Ignacio Marín-Jiménez, Belén Botella, Amparo Sapiña, Noelia Cruz, José Luis F. Forcelledo, Abdel Bouhmidi, Carlos Castaño-Milla, Verónica Opio, Isabel Nicolás, Marcos Kutz, Alfredo Abraldes Bechiarelli, Jordi Gordillo, Yolanda Ber, Yolanda Torres Domínguez, María Teresa Novella Durán, Silvia Rodríguez Mondéjar, Francisco J. Martínez-Cerezo, Lilyan Kolle, Miriam Sabat, Cesar Ledezma, Eduardo Iyo, Óscar Roncero, Rebeca Irisarri, Laia Lluis, Isabel Blázquez Gómez, Eva María Zapata, María José Alcalá, Cristina Martínez Pascual, María Montealegre, Laura Mata, Ana Monrobel, Alejandro Hernández Camba, Luis Hernández, María Tejada, Alberto Mir, María Luisa Galve, Marta Soler, Daniel Hervías, José Antonio Gómez-Valero, Manuel Barreiro-de Acosta, Fernando Rodríguez-Artalejo, Esther García-Esquinas, Javier P. Gisbert and on behalf of the EpidemIBD Study Group of GETECCUadd Show full author list remove Hide full author list
J. Clin. Med. 2022, 11(19), 5816; https://doi.org/10.3390/jcm11195816 - 30 Sep 2022
Cited by 4 | Viewed by 2438
Abstract
The authors wish to make the following corrections to this paper [...] Full article
12 pages, 858 KiB  
Article
MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction
by Ascensión M. de los Reyes-García, José Miguel Rivera-Caravaca, Laura Zapata-Martínez, Sonia Águila, Andrea Véliz-Martínez, Nuria García-Barberá, Pablo Gil-Perez, Pedro J. Guijarro-Carrillo, Esteban Orenes-Piñero, Cecilia López-García, María L. Lozano, Francisco Marín, Constantino Martínez and Rocío González-Conejero
J. Pers. Med. 2022, 12(7), 1185; https://doi.org/10.3390/jpm12071185 - 20 Jul 2022
Cited by 6 | Viewed by 3147
Abstract
Studies on older patients have established notable conceptual changes in the etiopathogenesis of acute coronary syndrome (ACS), but little is known about this disease in young patients (<45 years). Of special interest is thromboinflammation, key at onset, evolution and therapy of cardiovascular pathology. [...] Read more.
Studies on older patients have established notable conceptual changes in the etiopathogenesis of acute coronary syndrome (ACS), but little is known about this disease in young patients (<45 years). Of special interest is thromboinflammation, key at onset, evolution and therapy of cardiovascular pathology. Therefore, we explored whether ACS at an early age is a thromboinflammatory disease by analyzing NETs and rs2431697 of miR-146a (a miRNA considered as a brake of TLR/NF-kB pathway), elements previously related to higher rates of recurrence in atrial fibrillation and sepsis. We included 359 ACS patients (<45 years) and classified them for specific analysis into G1 (collected during the hospitalization of the first event), G2 and G3 (retrospectively collected from patients with or without ACS recurrence, respectively). cfDNA and citH3–DNA were quantified, and rs2431697 was genotyped. Analysis in the overall cohort showed a moderate but significant correlation between cfDNA and citH3–DNA and Killip–Kimball score. In addition, patients with citH3–DNA > Q4 more frequently had a history of previous stroke (6.1% vs. 1.6%). In turn, rs2431697 did not confer increased risk for the onset of ACS, but T carriers had significantly higher levels of NET markers. By groups, we found that cfDNA levels were similarly higher in all patients, but citH3–DNA was especially higher in G1, suggesting that in plasma, this marker may be attenuated over time. Finally, patients from G2 with the worst markers (cfDNA and citH3–DNA > Q2 and T allele) had a two-fold increased risk of a new ischemic event at 2-year follow-up. In conclusion, our data confirm that ACS is younger onset with thromboinflammatory disease. In addition, these data consolidate rs2431697 as a silent proinflammatory factor predisposing to NETosis, and to a higher rate of adverse events in different cardiovascular diseases. Full article
(This article belongs to the Section Clinical Medicine, Cell, and Organism Physiology)
Show Figures

Figure 1

19 pages, 1141 KiB  
Article
Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
by Manuel Durán-Ferrer, Rubén Villalba, Paloma Fernández-Pacheco, Cristina Tena-Tomás, Miguel-Ángel Jiménez-Clavero, José-Antonio Bouzada, María-José Ruano, Jovita Fernández-Pinero, Marisa Arias, Javier Castillo-Olivares and Montserrat Agüero
Viruses 2022, 14(7), 1545; https://doi.org/10.3390/v14071545 - 15 Jul 2022
Cited by 3 | Viewed by 2398
Abstract
This study described the clinical, virological, and serological responses of immunologically naïve and vaccinated horses to African horse sickness virus (AHSV) serotype 9. Naïve horses developed a clinical picture resembling the cardiac form of African horse sickness. This was characterized by inappetence, reduced [...] Read more.
This study described the clinical, virological, and serological responses of immunologically naïve and vaccinated horses to African horse sickness virus (AHSV) serotype 9. Naïve horses developed a clinical picture resembling the cardiac form of African horse sickness. This was characterized by inappetence, reduced activity, and hyperthermia leading to lethargy and immobility–recumbency by days 9–10 post-infection, an end-point criteria for euthanasia. After challenge, unvaccinated horses were viremic from days 3 or 4 post-infection till euthanasia, as detected by serogroup-specific (GS) real time RT-PCR (rRT-PCR) and virus isolation. Virus isolation, antigen ELISA, and GS-rRT-PCR also demonstrated high sensitivity in the post-mortem detection of the pathogen. After infection, serogroup-specific VP7 antibodies were undetectable by blocking ELISA (b-ELISA) in 2 out of 3 unvaccinated horses during the course of the disease (9–10 dpi). Vaccinated horses did not show significant side effects post-vaccination and were largely asymptomatic after the AHSV-9 challenge. VP7-specific antibodies could not be detected by the b-ELISA until day 21 and day 30 post-inoculation, respectively. Virus neutralizing antibody titres were low or even undetectable for specific serotypes in the vaccinated horses. Virus isolation and GS-rRT-PCR detected the presence of AHSV vaccine strains genomes and infectious vaccine virus after vaccination and challenge. This study established an experimental infection model of AHSV-9 in horses and characterized the main clinical, virological, and immunological parameters in both immunologically naïve and vaccinated horses using standardized bio-assays. Full article
(This article belongs to the Special Issue Viral Cycle and Cell Host Interactions of Equine Viruses)
Show Figures

Figure 1

14 pages, 1448 KiB  
Article
West Nile Virus Lineage 2 Spreads Westwards in Europe and Overwinters in North-Eastern Spain (2017–2020)
by Pilar Aguilera-Sepúlveda, Sebastián Napp, Francisco Llorente, Carlos Solano-Manrique, Rafael Molina-López, Elena Obón, Alba Solé, Miguel Ángel Jiménez-Clavero, Jovita Fernández-Pinero and Núria Busquets
Viruses 2022, 14(3), 569; https://doi.org/10.3390/v14030569 - 9 Mar 2022
Cited by 19 | Viewed by 3710
Abstract
West Nile virus lineage 2 (WNV-L2) emerged in Europe in 2004; since then, it has spread across the continent, causing outbreaks in humans and animals. During 2017 and 2020, WNV-L2 was detected and isolated from four northern goshawks in two provinces of Catalonia [...] Read more.
West Nile virus lineage 2 (WNV-L2) emerged in Europe in 2004; since then, it has spread across the continent, causing outbreaks in humans and animals. During 2017 and 2020, WNV-L2 was detected and isolated from four northern goshawks in two provinces of Catalonia (north-eastern Spain). In order to characterise the first Spanish WNV-L2 isolates and elucidate the potential overwintering of the virus in this Mediterranean region, complete genome sequencing, phylogenetic analyses, and a study of phenotypic characterisation were performed. Our results showed that these Spanish isolates belonged to the central-southern WNV-L2 clade. In more detail, they were related to the Lombardy cluster that emerged in Italy in 2013 and has been able to spread westwards, causing outbreaks in France (2018) and Spain (2017 and 2020). Phenotypic characterisation performed in vitro showed that these isolates presented characteristics corresponding to strains of moderate to high virulence. All these findings evidence that these WNV-L2 strains have been able to circulate and overwinter in the region, and are pathogenic, at least in northern goshawks, which seem to be very susceptible to WNV infection and may be good indicators of WNV-L2 circulation. Due to the increasing number of human and animal cases in Europe in the last years, this zoonotic flavivirus should be kept under extensive surveillance, following a One-Health approach. Full article
Show Figures

Figure 1

Back to TopTop